Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trial

por Aamir, Azizul Hasan, Raja, Umar Yousaf, Qureshi, Faisal Masood, Asghar, Ali, Mahar, Saeed Ahmed, Ahmed, Ibrar, Ghaffar, Tahir, Zafar, Jamal, Hasan, Mohammad Imtiaz, Riaz, Amna, Raza, Syed Abbas, Khosa, Irshad Ahmed, Khan, Jahanzeb, Baqar, Jaffer Bin
Publicado 2022

Asymptomatic urinary tract infections and associated risk factors in Pakistani Muslim type 2 diabetic patients

por Aamir, Azizul Hasan, Raja, Umar Yousuf, Asghar, Ali, Mahar, Saeed Ahmed, Ghaffar, Tahir, Ahmed, Ibrar, Qureshi, Faisal Masood, Zafar, Jamal, Hasan, Mohammad Imtiaz, Riaz, Amna, Raza, Syed Abbas, Khosa, Irshad Ahmed, Khan, Jahanzeb, Raza, Mahwish, Baqar, Jaffer Bin
Publicado 2021